Dr. Bhaskar Das, professor of pharmaceutical sciences, earned a grant from Insparin Therapeutics Inc. to develop potential treatments for insulin resistance, diabetes and hepatic steatosis. Dr. Das is testing the dose optimization, efficacy and safety of small molecules (peptidomimetics) that mimic peptides derived from adenovirus shown to improve glycemic control when tested in mice.
